Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Aedes | 4 | 2017 | 380 | 0.83 | Why? |
| Mosquito Vectors | 3 | 2017 | 351 | 0.72 | Why? |
| Chickenpox Vaccine | 1 | 2018 | 59 | 0.70 | Why? |
| Chikungunya Fever | 2 | 2017 | 345 | 0.63 | Why? |
| Culicidae | 1 | 2017 | 239 | 0.60 | Why? |
| Spatio-Temporal Analysis | 2 | 2018 | 1182 | 0.57 | Why? |
| Measles | 2 | 2018 | 608 | 0.53 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.53 | Why? |
| Herpes Zoster | 1 | 2018 | 331 | 0.50 | Why? |
| Dengue Virus | 2 | 2018 | 910 | 0.45 | Why? |
| Disease Outbreaks | 9 | 2021 | 27595 | 0.42 | Why? |
| Zika Virus Infection | 3 | 2018 | 1920 | 0.39 | Why? |
| Dengue | 2 | 2018 | 1565 | 0.37 | Why? |
| Cost-Benefit Analysis | 1 | 2018 | 2259 | 0.36 | Why? |
| Italy | 15 | 2021 | 38444 | 0.35 | Why? |
| Contact Tracing | 5 | 2021 | 8448 | 0.33 | Why? |
| Models, Theoretical | 6 | 2021 | 6659 | 0.33 | Why? |
| Insect Vectors | 2 | 2017 | 227 | 0.30 | Why? |
| Zika Virus | 2 | 2017 | 1924 | 0.29 | Why? |
| Mosquito Control | 2 | 2017 | 237 | 0.29 | Why? |
| Models, Biological | 7 | 2020 | 4907 | 0.29 | Why? |
| Communicable Disease Control | 5 | 2021 | 29620 | 0.26 | Why? |
| Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.25 | Why? |
| Occupational Exposure | 1 | 2021 | 4742 | 0.24 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.21 | Why? |
| Quarantine | 4 | 2021 | 18418 | 0.20 | Why? |
| Population Dynamics | 3 | 2017 | 378 | 0.20 | Why? |
| Epidemics | 6 | 2018 | 6407 | 0.19 | Why? |
| Patient-Specific Modeling | 1 | 2018 | 60 | 0.18 | Why? |
| Animal Distribution | 1 | 2017 | 23 | 0.18 | Why? |
| Public Health | 3 | 2020 | 16359 | 0.18 | Why? |
| Basic Reproduction Number | 2 | 2020 | 2676 | 0.17 | Why? |
| Schools | 4 | 2021 | 4187 | 0.17 | Why? |
| Murinae | 1 | 2017 | 25 | 0.17 | Why? |
| Ethiopia | 2 | 2021 | 1222 | 0.17 | Why? |
| Chikungunya virus | 2 | 2017 | 339 | 0.17 | Why? |
| Embolism | 1 | 2018 | 136 | 0.17 | Why? |
| Culex | 1 | 2017 | 66 | 0.16 | Why? |
| Hantavirus Infections | 1 | 2017 | 62 | 0.16 | Why? |
| Hantavirus | 1 | 2017 | 63 | 0.16 | Why? |
| Rodent Diseases | 1 | 2017 | 115 | 0.16 | Why? |
| Child Day Care Centers | 1 | 2018 | 208 | 0.15 | Why? |
| Insecticides | 1 | 2017 | 178 | 0.15 | Why? |
| Hemorrhagic Fever, Ebola | 2 | 2017 | 1475 | 0.15 | Why? |
| Chickenpox | 1 | 2018 | 194 | 0.14 | Why? |
| Health Services Accessibility | 1 | 2018 | 10697 | 0.14 | Why? |
| Measles Vaccine | 1 | 2017 | 301 | 0.14 | Why? |
| Bayes Theorem | 3 | 2018 | 3237 | 0.13 | Why? |
| Age Distribution | 2 | 2020 | 3567 | 0.13 | Why? |
| Infant | 7 | 2021 | 30274 | 0.13 | Why? |
| Child, Preschool | 8 | 2021 | 36283 | 0.13 | Why? |
| Hospitalization | 4 | 2021 | 54280 | 0.12 | Why? |
| Infant, Newborn | 5 | 2021 | 23105 | 0.12 | Why? |
| Seroepidemiologic Studies | 4 | 2021 | 10017 | 0.12 | Why? |
| Incidence | 6 | 2020 | 25622 | 0.12 | Why? |
| Geography | 1 | 2018 | 1801 | 0.12 | Why? |
| Health Personnel | 2 | 2021 | 29646 | 0.11 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.11 | Why? |
| Positive-Pressure Respiration | 1 | 2020 | 1160 | 0.11 | Why? |
| Humans | 34 | 2021 | 930598 | 0.11 | Why? |
| Models, Statistical | 6 | 2020 | 5312 | 0.11 | Why? |
| Seasons | 3 | 2017 | 4071 | 0.10 | Why? |
| Pandemics | 10 | 2021 | 389249 | 0.10 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.10 | Why? |
| Female | 20 | 2021 | 380317 | 0.10 | Why? |
| Male | 19 | 2021 | 367725 | 0.10 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.10 | Why? |
| Carrier State | 1 | 2021 | 2100 | 0.09 | Why? |
| Adolescent | 10 | 2021 | 86841 | 0.09 | Why? |
| Interpersonal Relations | 1 | 2017 | 926 | 0.09 | Why? |
| Pneumonia, Viral | 7 | 2020 | 243684 | 0.09 | Why? |
| Coronavirus Infections | 7 | 2020 | 253789 | 0.09 | Why? |
| Social Behavior | 1 | 2017 | 882 | 0.09 | Why? |
| Child | 8 | 2021 | 70012 | 0.09 | Why? |
| Young Adult | 9 | 2021 | 93724 | 0.09 | Why? |
| Adult | 12 | 2021 | 244371 | 0.08 | Why? |
| Dyspnea | 1 | 2021 | 3847 | 0.08 | Why? |
| Cough | 1 | 2021 | 4891 | 0.08 | Why? |
| Immunoglobulin G | 2 | 2021 | 21571 | 0.08 | Why? |
| Cities | 1 | 2018 | 4937 | 0.08 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.07 | Why? |
| Stochastic Processes | 2 | 2017 | 369 | 0.07 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.07 | Why? |
| Aged | 10 | 2021 | 215776 | 0.07 | Why? |
| Animals | 7 | 2018 | 78931 | 0.07 | Why? |
| Genes | 1 | 2003 | 50 | 0.07 | Why? |
| Entropy | 1 | 2003 | 52 | 0.07 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.07 | Why? |
| Travel | 2 | 2020 | 7220 | 0.07 | Why? |
| Pregnant Women | 1 | 2017 | 2535 | 0.07 | Why? |
| Betacoronavirus | 7 | 2020 | 204454 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Brazil | 2 | 2018 | 12582 | 0.07 | Why? |
| Influenza, Human | 2 | 2018 | 10779 | 0.06 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2017 | 2984 | 0.06 | Why? |
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 343 | 0.06 | Why? |
| Algorithms | 2 | 2018 | 7346 | 0.06 | Why? |
| Time Factors | 3 | 2020 | 31397 | 0.06 | Why? |
| Communicable Diseases | 1 | 2017 | 2148 | 0.06 | Why? |
| Infection Control | 2 | 2021 | 23131 | 0.06 | Why? |
| History, 21st Century | 2 | 2018 | 1849 | 0.05 | Why? |
| Age Factors | 5 | 2021 | 21039 | 0.05 | Why? |
| Disease Susceptibility | 3 | 2020 | 4002 | 0.05 | Why? |
| Vaccination | 3 | 2021 | 19050 | 0.05 | Why? |
| Tachypnea | 1 | 2021 | 197 | 0.05 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.05 | Why? |
| Epidemiologic Factors | 1 | 2018 | 11 | 0.05 | Why? |
| Urban Renewal | 1 | 2017 | 25 | 0.04 | Why? |
| Liberia | 1 | 2017 | 108 | 0.04 | Why? |
| Behavior | 1 | 2020 | 252 | 0.04 | Why? |
| Larva | 1 | 2017 | 153 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2019 | 10083 | 0.04 | Why? |
| Product Surveillance, Postmarketing | 1 | 2019 | 189 | 0.04 | Why? |
| Boston | 1 | 2020 | 929 | 0.04 | Why? |
| Pharyngitis | 1 | 2021 | 687 | 0.04 | Why? |
| Zimbabwe | 1 | 2017 | 198 | 0.04 | Why? |
| China | 5 | 2021 | 50654 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2021 | 15978 | 0.04 | Why? |
| Chest Pain | 1 | 2021 | 578 | 0.04 | Why? |
| Critical Care | 1 | 2020 | 14081 | 0.04 | Why? |
| Herpesvirus 3, Human | 1 | 2018 | 228 | 0.04 | Why? |
| Competitive Behavior | 1 | 2017 | 111 | 0.04 | Why? |
| Retrospective Studies | 4 | 2021 | 105322 | 0.04 | Why? |
| Americas | 1 | 2017 | 418 | 0.04 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.04 | Why? |
| Africa, Western | 1 | 2017 | 363 | 0.04 | Why? |
| Microcephaly | 1 | 2017 | 181 | 0.04 | Why? |
| Stroke | 1 | 2018 | 8839 | 0.04 | Why? |
| Computer Simulation | 2 | 2020 | 4982 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.03 | Why? |
| United States | 2 | 2018 | 46150 | 0.03 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Epidemiologic Methods | 1 | 2017 | 392 | 0.03 | Why? |
| Species Specificity | 1 | 2017 | 1356 | 0.03 | Why? |
| Sex Distribution | 1 | 2020 | 2083 | 0.03 | Why? |
| Forecasting | 2 | 2017 | 4492 | 0.03 | Why? |
| Climate | 1 | 2017 | 557 | 0.03 | Why? |
| Gene Expression Profiling | 1 | 2003 | 3788 | 0.03 | Why? |
| History, 20th Century | 1 | 2018 | 1282 | 0.03 | Why? |
| Population Density | 1 | 2017 | 694 | 0.03 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2019 | 1115 | 0.03 | Why? |
| Microbial Sensitivity Tests | 1 | 2019 | 2886 | 0.03 | Why? |
| Family Characteristics | 1 | 2020 | 2551 | 0.02 | Why? |
| Netherlands | 1 | 2018 | 3533 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Workplace | 1 | 2020 | 2075 | 0.02 | Why? |
| Internationality | 1 | 2020 | 3297 | 0.02 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.02 | Why? |
| Prevalence | 2 | 2018 | 25773 | 0.02 | Why? |
| England | 1 | 2017 | 5116 | 0.02 | Why? |
| Poverty | 1 | 2017 | 2302 | 0.02 | Why? |
| Reproducibility of Results | 2 | 2017 | 11304 | 0.02 | Why? |
| Genes, Neoplasm | 1 | 2003 | 26 | 0.02 | Why? |
| DNA, Neoplasm | 1 | 2003 | 56 | 0.02 | Why? |
| Selection Bias | 1 | 2003 | 201 | 0.02 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| France | 1 | 2018 | 12074 | 0.01 | Why? |
| DNA, Complementary | 1 | 2003 | 568 | 0.01 | Why? |
| Longitudinal Studies | 1 | 2017 | 9893 | 0.01 | Why? |
| Europe | 1 | 2017 | 12702 | 0.01 | Why? |
| Aging | 1 | 2017 | 3581 | 0.01 | Why? |
| Randomized Controlled Trials as Topic | 1 | 2019 | 10649 | 0.01 | Why? |
| Colonic Neoplasms | 1 | 2003 | 295 | 0.01 | Why? |
| Lymphoma | 1 | 2003 | 522 | 0.01 | Why? |
| Databases, Genetic | 1 | 2003 | 1127 | 0.01 | Why? |
| Adenocarcinoma | 1 | 2003 | 651 | 0.01 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2018 | 9044 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2020 | 22116 | 0.01 | Why? |
| Cohort Studies | 1 | 2018 | 36005 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Risk Assessment | 1 | 2018 | 25439 | 0.01 | Why? |
| Global Health | 1 | 2017 | 13911 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.01 | Why? |
| Artificial Intelligence | 1 | 2003 | 3543 | 0.01 | Why? |
| Predictive Value of Tests | 1 | 2003 | 9537 | 0.01 | Why? |
Merler's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(179)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(166)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_